ProMIS Neurosciences annual return on equity
2022
2023
2024
2025
ProMIS Neurosciences Return on Equity (ROE) Growth & History (PMN)
ProMIS Neurosciences's return on equity was −521.61% for fiscal 2025.
View full ProMIS Neurosciences company overviewProMIS Neurosciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −521.61% | −549.06 pp |
| 2024 | 2024-12-31 | 27.46% | +1125.97 pp |
| 2023 | 2023-12-31 | −1,098.51% | −260.80 pp |
| 2022 | 2022-12-31 | −837.71% | — |
ProMIS Neurosciences quarterly return on equity
Q2.22
Q3.22
Q4.23
Q1.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −21.30% | +201.31 pp |
| Q1 2026 | 2026-03-31 | −27.73% | +28.88 pp |
| Q4 2025 | 2025-12-31 | −269.25% | −267.24 pp |
| Q3 2025 | 2025-09-30 | −263.04% | −634.36 pp |
| Q2 2025 | 2025-06-30 | −222.62% | — |
| Q1 2025 | 2025-03-31 | −56.61% | +133.19 pp |
| Q4 2024 | 2024-12-31 | −2.00% | +66.14 pp |
| Q3 2024 | 2024-09-30 | 371.32% | — |
| Q1 2024 | 2024-03-31 | −189.80% | — |
| Q4 2023 | 2023-12-31 | −68.15% | — |
| Q3 2022 | 2022-09-30 | −160.14% | — |
| Q2 2022 | 2022-06-30 | −44.38% | — |
ProMIS Neurosciences return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, ProMIS Neurosciences's return on equity increased from −837.71% to −521.61%, a change of +316.11 percentage points. The latest reported quarter, Q2 2026, shows −21.30%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ProMIS Neurosciences source filings ↗